The trademark application GAMIDA CELL ASSIST was filed by Gamida Cell Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on March 22, 2020, and it was registered by office on June 30, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 4, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 6, 2021. A transfer of the trademark registration was recorded on April 10, 2024.
Goods And Services
The mark was filed in class 35 with following description of goods:
Promoting public awareness of issues related to the testing, diagnosis, treatment and patient outcome in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders
Advocating for needs of patients with cancer, and blood and bone marrow diseases and disorders
Administration of a patient assistance program for providing prescription drugs at reduced cost.
The mark was filed in class 36 with Providing information regarding insurance coverage and reimbursement for prescription drugs.
The mark was filed in class 44 with following description of goods:
Providing educational medical information in the fields of in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders, including the testing, diagnosis, treatment and patient outcomes related thereto
Medical services, namely, providing information regarding prescription drugs and disease treatment
Providing a call center for responding to patient and caregiver inquiries and providing guidance in the field of prescription pharmaceuticals and disease treatment.